1134191-24-4

Basic information

• Product Name: 4-(5-thioxo-5H-1,2-dithiol-3-yl)phenyl (6R,12aR)-2,3,6,7,12,12a-hexahydro-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione-2-acetate
• Synonyms: 4-(5-thioxo-5H-1,2-dithiol-3-yl)phenyl (6R,12aR)-2,3,6,7,12,12a-hexahydro-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione-2-acetate
• CAS NO: 1134191-24-4
• Molecular Weight: 641.749
• Mol File: 1134191-24-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(5-thioxo-5H-1,2-dithiol-3-yl)phenyl (6R,12aR)-2,3,6,7,12,12a-hexahydro-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione-2-acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-thioxo-5H-1,2-dithiol-3-yl)phenyl (6R,12aR)-2,3,6,7,12,12a-hexahydro-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione-2-acetate(1134191-24-4)
• EPA Substance Registry System: 4-(5-thioxo-5H-1,2-dithiol-3-yl)phenyl (6R,12aR)-2,3,6,7,12,12a-hexahydro-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione-2-acetate(1134191-24-4)

Safety Data

• Hazardous Substances Data: 1134191-24-4(Hazardous Substances Data)

Upstream product

• 385770-82-1 ((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino-[1',2':1,6]pyrido[3,4-b]indol-2-yl)acetic acid 
• 18274-81-2 desmethyl anethole trithione 
• 385771-08-4 ((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino-[1',2':1,6]pyrido[3,4-b]indol-2-yl)acetic acid methyl ester 
• 120-57-0 piperonal 
• 495-76-1 piperonol 
• 532-11-6 anethole trithione 
• 153-94-6 D-tryptophan 
• 171489-59-1 methyl (1R,3R)-1-(3,4-methylenedioxyphenyl)-2-chloroacetyl-2,3,4,9-tetrahydro-9H-pyrido[3,4-b]indol-3-carboxylate 
• 171752-68-4 (1R,3R)-1-benzo[1,3]dioxol-5-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid methyl ester hydrochloride 

Relevant articles and documents

NEW AGENTS FOR THE TREATMENT OF THE LOW URINARY TRACT DYSFUNCTIONS

The present invention relates to novel compounds that are derivatives of 5 -phosphodiesterase inhibitors that comprise in their formula a polysulfurated group and that are useful for treating dysfunctions of low urinary tract such as incontinence, benign prostatic hyperplasia and erectile dysfunction.